Medical Cannabis for Best Supportive Care of Patients Affected by Cancers of the Head and Neck: A Narrative Review
Abstract Cancers of the head and neck, including malignancies of the oral cavity, pharynx, larynx, and salivary glands, are often…
Abstract Cancers of the head and neck, including malignancies of the oral cavity, pharynx, larynx, and salivary glands, are often…
Abstract The Catalan Institute of Oncology (ICO) is a comprehensive centre for the prevention, diagnosis, and treatment of cancer. At…
Abstract Background: The incidence of papillary thyroid cancer (PTC) continues to rise all over the world, 10–15% of the patients…
Abstract Annexins are an extensive superfamily of structurally related calcium- and phospholipid-binding proteins, largely conserved and widely distributed among species.…
Abstract Chemoresistance is the leading cause of poor prognosis in head and neck squamous cell carcinoma (HNSC); however, promising biomarkers…
Abstract Introduction: Patients with head and neck cancer (HNC) are usually confronted with functional changes due to the malignancy itself…
Abstract Background: Cannabis has been rapidly legalized in North America; however, limited evidence exists around its side effects. Health Canada…
Abstract Forkhead box D1 (FOXD1) is a new member of FOX transcription factor family. FOXD1 has demonstrated multilevel roles during…
Abstract Noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) are follicular-patterned thyroid neoplasms defined by nuclear atypia and indolent…
Abstract Cannabidiol (CBD) has anti-tumorigenic activity. However, the anti-cancer effect of CBD on head and neck squamous cell carcinoma (HNSCC)…